MAPT and Alzheimer disease: Owing to the lack of Aβ or Tau-related markers, we were unable to analyze the relationship between those pathological markers and ocular measurements, and hence the present findings cannot directly confirm whether the alterations in the ophthalmological examinations are specific to AD.